Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails
Status:
Unknown status
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
To observe and access the Effects and safety of terlipressin or high dose
somatostatin/octreotide when usual dose somatostatin/octreotide fail to achieve hemostasis in
patients with acute variceal bleeding.